Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing's Syndrome
A growing body of research indicates that cortisol, the glucocorticoid product of the activation of the hypothalamic-pituitary-adrenal axis, plays a role in the pathophysiology of metabolic syndrome. In this regard, chronic exposure to cortisol is associated with risk factors related to metabolic sy...
Saved in:
Main Authors: | Francisco Díaz-Castro (Author), Matías Monsalves-Álvarez (Author), Leonel E. Rojo (Author), Andrea del Campo (Author), Rodrigo Troncoso (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cushing's syndrome in a child
by: Kalyan Dutta, et al.
Published: (2021) -
Ectopic Cushing syndrome presenting as hyperpigmentation
by: Pooja Arora, et al.
Published: (2022) -
DYNAMICS OF PSYCHIATRIC SYMPTOMS IN CUSHING'S SYNDROME
by: Tatyana Telbizova, et al.
Published: (2020) -
Cushing's Syndrome: A Large Adenoma of Adrenal Gland
by: M Adi Soedarso, et al.
Published: (2019) -
Iatrogenic cushing's syndrome in patients with superficial dermatophytosis
by: Priyesh Thakran, et al.
Published: (2021)